Journal of Nutrition and Health

  • 제57권1호
  • /
  • Pages.75-87
  • /
  • 2024
  • /
  • 2288-3886(pISSN)
  • /
  • 2288-3959(eISSN)
한국영양학회 (The Korean Nutrition Society)
권호 표지
DOI QR코드

DOI QR Code

Effect of web-based personalized nutrition management on gut microbiota in Korean patients with irritable bowel syndrome aged between 20 and 30 years

  • Woori Na (Department of Food and Nutrition, Wonkwang University) ;
  • Dayoung Oh (Department of Food and Nutrition, Wonkwang University) ;
  • Seohyeon Hwang (Department of Food and Nutrition, Wonkwang University) ;
  • Cheongmin Sohn (Department of Food and Nutrition, Wonkwang University)
  • 투고 : 2023.11.22
  • 심사 : 2024.01.11
  • 발행 : 2024.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Dietary habits are strongly related to the symptoms of people with irritable bowel syndrome (IBS). Therefore, personalized nutrition management can help reduce symptoms and improve the quality of life of people with IBS. This study assessed the effectiveness of a personalized web-based nutrition management based on the types of food that trigger IBS symptoms. Methods: Sixty Korean adults with IBS according to Rome IV criteria in their 20s and 30s were enrolled in this study. The data from the final 49 patients who completed a three-month personalized nutrition intervention were analyzed. The general information, anthropometry, dietary intake survey, and gut microbiota were examined pre and post-intervention. The gut microbiota analysis included the relative abundance and the Shannon index. The food intake was recorded for two days for personalized nutrition education, followed by three months of personalized nutrition intervention. Statistical analysis was performed using the Wilcoxon signed-rank test in SPSS 26.0, with the significance set to p < 0.05. Results: The relative abundance of the gut microbiota changed after personalized nutrition management, with a significant decrease in the presence of Veillonella (p = 0.048). Furthermore, when the gut microbiota was analyzed according to the type of food that triggers symptoms, the diversity was increased significantly in the high fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) type (p = 0.031) and FODMAPs-containing gluten-type personalized nutrition intervention types (p < 0.001). Conclusions: Gut microbial diversity and gut microbiota distribution changed after using web-based personalized nutrition management. Hence, personalized nutrition management that considers trigger foods may improve IBS symptoms.

키워드

과제정보

This work was supported by the National Research Foundation of Kore (NRF) grant funded by the Korea Government (MSIP) (No. NRF-2020R1A2C1014177).

참고문헌

  1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130(5): 1377-1390. https://doi.org/10.1053/j.gastro.2006.03.008
  2. Miwa H. Life style in persons with functional gastrointestinal disorders--large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil 2012; 24(5): 464-471. https://doi.org/10.1111/j.1365-2982.2011.01872.x
  3. Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol 2012; 107(5): 657-666. https://doi.org/10.1038/ajg.2012.49
  4. McKenzie YA, Bowyer RK, Leach H, Gulia P, Horobin J, O'Sullivan NA, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016; 29(5): 549-575. https://doi.org/10.1111/jhn.12385
  5. Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 2017; 15(1): 35. 
  6. Rafferty AJ, Hall R, Johnston CS. A novel mobile app (Heali) for disease treatment in participants with irritable bowel syndrome: randomized controlled pilot trial. J Med Internet Res 2021; 23(3): e24134. 
  7. Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, et al. Influence of diet on the gut microbiome and implications for human health. J Transl Med 2017; 15(1): 73.
  8. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307(5717): 1915-1920. https://doi.org/10.1126/science.1104816
  9. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81(3): 1031-1064. https://doi.org/10.1152/physrev.2001.81.3.1031
  10. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330(6012): 1768-1773. https://doi.org/10.1126/science.1195568
  11. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9(5): 313-323. https://doi.org/10.1038/nri2515
  12. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016; 150(6): 1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035
  13. Hwang S, Na W, Oh D, Sohn C. Development and evaluation of a web-based self-management program for Korean adult patients with irritable bowel syndrome based on the Information-Motivation-Behavioral skills model. Appl Sci 2023; 13(12): 6915.
  14. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990; 300(6722): 439-440. https://doi.org/10.1136/bmj.300.6722.439
  15. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form. J Korean Acad Fam Med 2007; 28(7): 532-541.
  16. Kim KN, Park JY, Shin TS, Jun KJ, Choi EY, Kim HJ, et al. Degree of stress and stress-related factors by the Korean version of the BEPSI. J Korean Acad Fam Med 1998; 19(7): 559-570.
  17. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11(2): 395-402.  https://doi.org/10.1046/j.1365-2036.1997.142318000.x
  18. Na W, Lee Y, Kim H, Kim YS, Sohn C. High-fat foods and FODMAPs containing gluten foods primarily contribute to symptoms of irritable bowel syndrome in Korean adults. Nutrients 2021; 13(4): 1308. 
  19. Lee HJ, Kim HJ, Kang EH, Jung KW, Myung SJ, Min YW, et al. Self-reported food intolerance in Korean patients with irritable bowel syndrome. J Neurogastroenterol Motil 2019; 25(2): 222-232. https://doi.org/10.5056/jnm18125
  20. Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100(2): 373-382. https://doi.org/10.1111/j.1572-0241.2005.40312.x
  21. Shukla R, Ghoshal U, Dhole TN, Ghoshal UC. Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis. Dig Dis Sci 2015; 60(10): 2953-2962. https://doi.org/10.1007/s10620-015-3607-y
  22. Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L. Fecal microbiota alterations associated with diarrheapredominant irritable bowel syndrome. Front Microbiol 2018; 9: 1600.
  23. Treem WR, Ahsan N, Kastoff G, Hyams JS. Fecal short-chain fatty acids in patients with diarrheapredominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996; 23(3): 280-286.
  24. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22(5): 512-519. https://doi.org/10.1111/j.1365-2982.2009.01427.x
  25. Zhu S, Liu S, Li H, Zhang Z, Zhang Q, Chen L, et al. Identification of gut microbiota and metabolites signature in patients with irritable bowel syndrome. Front Cell Infect Microbiol 2019; 9: 346.
  26. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17(12): 1519-1528. https://doi.org/10.3748/wjg.v17.i12.1519
  27. Rangel I, Sundin J, Fuentes S, Repsilber D, de Vos WM, Brummer RJ. The relationship between faecalassociated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects. Aliment Pharmacol Ther 2015; 42(10): 1211-1221. https://doi.org/10.1111/apt.13399
  28. Jacobs JP, Lagishetty V, Hauer MC, Labus JS, Dong TS, Toma R, et al. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes. Microbiome 2023; 11(1): 5. 
  29. Enck P, Mazurak N. Dysbiosis in functional bowel disorders. Ann Nutr Metab 2018; 72(4): 296-306.  https://doi.org/10.1159/000488773
  30. Bohn L, Storsrud S, Tornblom H, Bengtsson U, Simren M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013; 108(5): 634-641. https://doi.org/10.1038/ajg.2013.105
  31. Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National survey on patient educational needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007; 102(9): 1972-1982. https://doi.org/10.1111/j.1572-0241.2007.01254.x
  32. Back J, Jun SE. The relationship of eating habits and trigger foods to symptom severity of irritable bowel syndrome. J Korean Biol Nurs Sci 2015; 17(4): 297-305. https://doi.org/10.7586/jkbns.2015.17.4.297
  33. Rijnaarts I, Witteman BJM, Zoetendal EG, Govers C, de Wit NJW, de Roos NM. Subtypes and severity of irritable bowel syndrome are not related to patients' self-reported dietary triggers: results from an online survey in Dutch adults. J Acad Nutr Diet 2021; 121(9): 1750-1762.e8. https://doi.org/10.1016/j.jand.2021.01.007
  34. Schumann D, Langhorst J, Dobos G, Cramer H. Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2018; 47(2): 203-211. https://doi.org/10.1111/apt.14400